Exact Sciences
EXAS
#1548
Rank
โ‚น948.50 B
Marketcap
โ‚น5,125
Share price
-0.63%
Change (1 day)
-4.47%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Revenue for Exact Sciences (EXAS)

Revenue in 2024 (TTM): โ‚น224.63 Billion

According to Exact Sciences's latest financial reports the company's current revenue (TTM ) is โ‚น228.55 Billion. In 2023 the company made a revenue of โ‚น208.10 Billion an increase over the revenue in the year 2022 that were of โ‚น172.47 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Exact Sciences from 2001 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น224.63 B7.94%
2023 โ‚น208.10 B20.66%
2022 โ‚น172.47 B31.13%
2021 โ‚น131.52 B20.59%
2020 โ‚น109.07 B74.54%
2019 โ‚น62.48 B96.65%
2018 โ‚น31.77 B87.1%
2017 โ‚น16.98 B151.49%
2016 โ‚น6.75 B157.67%
2015 โ‚น2.62 B2199.87%
2014 โ‚น0.11 B-55.49%
2013 โ‚น0.25 B12.83%
2012 โ‚น0.22 B3.03%
2011 โ‚น0.22 B-8.04%
2010 โ‚น0.23 B8.47%
2009 โ‚น0.22 B
2007 โ‚น0.11 B-45.25%
2006 โ‚น0.21 B10%
2005 โ‚น0.19 B-10.52%
2004 โ‚น0.21 B61.81%
2003 โ‚น0.13 B207.06%
2002 โ‚น43.01 M1652.4%
2001 โ‚น2.45 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น69.91 B-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น15.61 B-93.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น36.10 B-84.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.3 Billion-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.542 T 1,887.39%๐Ÿ‡ซ๐Ÿ‡ท France